Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter (Q34491925)

2 August 2017

1 reference

title

Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter (English)

1 reference

2 August 2017

1 reference

P A Howard

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Annals of Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

33

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

38-47

1 reference

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

2 August 2017

cites work

1 reference

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

21 January 2018

1 reference

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

Epidemiology and mechanism of atrial fibrillation and atrial flutter

21 January 2018

1 reference

Acute treatment of atrial fibrillation and flutter

21 January 2018

1 reference

Atrial fibrillation 1992. Management strategies in flux

21 January 2018

1 reference

Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy

21 January 2018

1 reference

Electrophysiology and pharmacology of ibutilide

21 January 2018

1 reference

Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects.

21 January 2018

1 reference

Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation

21 January 2018

1 reference

Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability

21 January 2018

1 reference

Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation

21 January 2018

1 reference

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

21 January 2018

1 reference

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

21 January 2018

1 reference

Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients

21 January 2018

1 reference

Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion

21 January 2018

1 reference

Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size

21 January 2018

1 reference

Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the sotalol-digoxin-quinidine trial)

21 January 2018

1 reference

Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up

21 January 2018

1 reference

Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study.

21 January 2018

1 reference

Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation

21 January 2018

1 reference

Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study

21 January 2018

1 reference

Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter

21 January 2018

1 reference

Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm

21 January 2018

1 reference

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18097

1 reference

2 August 2017

1 reference